약물방출스텐트의 약물 방출 특성 평가 방법 개발
Development of Evaluation Method for Drug Release Propreties in Drug Eluting Stent
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The goal of this study is to develop test method for evaluating the drug eluting properties of drug eluting stents (DES). PBS and the detergent solutions, presented by each DES manufacturer, were used for drug release of DES coated with paclitaxel, zotarolimus and everolimus. The drugs which are coating DES were not released by PBS but released by the detergent solutions, finally paclitaxel 83.38%, zotarolimus 103.85% and everolimus 115.78%. It seems that the use of the detergents is necessary in order to release the drugs because those drugs are extremely hydrophobic. In conclusion, using of detergent solutions presented by each manufacturer were suitable for evaluating the drug eluting property of drug eluting stent.
Abstract
The goal of this study is to develop test method for evaluating the drug eluting properties of drug eluting stents (DES). PBS and the detergent solutions, presented by each DES manufacturer, were used for drug release of DES coated with paclitaxel, zotarolimus and everolimus. The drugs which are coating DES were not released by PBS but released by the detergent solutions, finally paclitaxel 83.38%, zotarolimus 103.85% and everolimus 115.78%. It seems that the use of the detergents is necessary in order to release the drugs because those drugs are extremely hydrophobic. In conclusion, using of detergent solutions presented by each manufacturer were suitable for evaluating the drug eluting property of drug eluting stent.
참고문헌 (12)
- 스텐트 시장동향, "한국보건산업진흥원", ~ (2005)
- P. A. Lemos, "Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the Real World", Circulation, 109, pp.190~195 (2004)
- S. J. Park, "Drug-Eluting Stent : Present and Future", J. Korean Med. Assoc, 51(4), pp.299~305 (2008)
- A. Seidlitz, "In vitro Dissolution Testing of Drug-Eluting Stents", Current Pharmaceutical Biotechnology, 14, pp.67~75 (2013)
- R. S. Schwartz, "Drug-Eluting Stents in Preclinical Studies : Recommendation Evaluation from a Consensus Group", Circulation, 106, pp.1867~1873 (2002)
- W. Khan, "Carrier Free Rapamycin Loaded Drug Eluting Stent : In Vitro and In vivo Evaluation", J Control Release, 168(1), pp.70~76 (2013)
- C. P. Naseerali, "The Release Kinetics of Drug Eluting Stents Containing Sirolimus as Coated Drug : Role of Release Media", J Chromatogr B Analyt Biomed Life Sci, 878, pp.709~712 (2010)
- S. Farah, "Crystalline Coating of Rapamycin onto a Stent : Process Development and Characterization", Int J Pharm, 10, pp.99~ (2013)
- K. Steigerwald, "The Pre-clinical Assessment of Rapamycin-Eluting, Durable Polymer-Free Stent Coating Concepts", Biomaterials, pp.1~6 (2008)
- R. S. Schwartz, "Drug-Eluting Stents in Preclinical Studies : Updated Concensus Recommendations for Preclinical Evaluation", Circ Cardiovasc Intervent, pp.141~153 (2008)
- M. Merciadez, "A Novel Method for the Elution of Sirolimus(Rapamycin)in Drug-Eluting Stents", Dissolution Technolodies, 18, pp.37~42 (2011)
- F. C. Nelson, "Manipulation of the C(22)-C(27)Region of Rapamycin : Stability Issues and Biological Implications", Bioorg Med Chem Lett, 9, pp.295~300 (1999)